Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0000899243-21-041838

10% owner acquired 2,602,264 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SV7 Impact Medicine Fund LP 10% owner 2021-10-26 Conversion +998,544 998,544 D: show line 1 in the form
SV7 Impact Medicine Fund LP 10% owner 2021-10-26 Conversion +998,544 998,544 I: show line 2 in the form
SV7 Impact Medicine Fund LP 10% owner 2021-10-26 Conversion +302,588 1,301,132 D: show line 3 in the form
SV7 Impact Medicine Fund LP 10% owner 2021-10-26 Conversion +302,588 1,301,132 I: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
SV7 Impact Medicine Fund LP 10% owner 2021-10-26 Conversion · Series B Convertible Preferred Stock −9,486,166 0 D: show line 5 in the form
SV7 Impact Medicine Fund LP 10% owner 2021-10-26 Conversion · Series B Convertible Preferred Stock −9,486,166 0 I: show line 6 in the form
SV7 Impact Medicine Fund LP 10% owner 2021-10-26 Conversion · Series C Convertible Preferred Stock −2,874,595 0 D: show line 7 in the form
SV7 Impact Medicine Fund LP 10% owner 2021-10-26 Conversion · Series C Convertible Preferred Stock −2,874,595 0 I: show line 8 in the form
Loading xslF345X03/doc4.xml…